- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
December 31st, 2006
Ahmedabad-based pharma major Dishman Pharmaceuticals and Chemicals (DPCL) is keen to acquire biotech and nanotechnology contract research organisation (CRO) companies in the US and Europe.
Talking to Business Standard, J R Vyas, MD of Dishman Pharma, said, "We are keen to acquire CROs companies operating in biotech and nanotechnolgy research."
|Related News Press|
Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016
Arrowhead to Present at Upcoming March Conferences March 1st, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016
UCLA nanoscientists engage shoppers in fun conversations March 8th, 2016
Risk Analysis Publishes Non-Animal Strategy to Assess Nanomaterials February 24th, 2016